Example: Heart Attack

Search clinical trials for: Girls Can...Move!

Total 6088 results

NCT04833504

Completed

Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma

Transformed Follicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B-cell Lymphoma | Primary Mediastinal Large B-cell Lymphoma
NCT04249947

Terminated

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Neoplasms | Neoplasms by Histologic Type | Urogenital Neoplasms | Neoplasms by Site | Genital Neoplasms, Male | Prostatic Neoplasms | Adenoid Cystic Carcinoma | Mucoepidermoid Carcinoma | Prostate Cancer | Prostatic Neoplasms, Castration-Resistant
NCT03288493

Terminated

P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)

Multiple Myeloma
NCT05682274

Active, not recruiting

Effect of Restoration Margin Level in the Treatment of Gingival Recession Associated With Non-carious Cervical Lesion

Gingival Recession, Localized
NCT04973527

Terminated

LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor

T-cell Leukemia | T Cell Lymphoma
NCT04219319

Terminated

LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T-cell Lymphoma

CD4+ T Lymphocyte Tumor (T Cell Lymphoma and T Cell Leukemia)
NCT04872296

Enrolling by invitation

Weight Bearing for Fibular Fractures

Fibula Fracture
NCT03649529

Unknown

Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy

Malignant Melanoma
NCT04014881

Unknown

Safety and Efficacy of Anti-CD123 CAR-T Therapy in Patients With Refractory/ Relapsed CD123+ Acute Myeloid Leukemia.

CD123+ Acute Myeloid Leukemia
NCT03998072

Unknown

Does Five Session CAT Consultancy Lead to Improved Outcomes?

Treatment as Usual | Psychological Intervention
NCT03267173

Unknown

Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer.

Pancreatic Cancer | CAR
NCT01433029

Completed

Objective Assessment of Technical Skills in Cardiothoracic Surgery

Other Surgical Procedures
NCT02794961

Unknown

CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies

Recurrent or Refractory B Cell Malignancy
NCT02247609

Unknown

Evaluation of 4th Generation Safety-designed CAR T Cells Targeting High-risk and Refractory B Cell Lymphomas (4SCAR19273)

B-cell Lymphomas
NCT00219453

Completed

Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination

Virus Diseases | Hepatitis B
NCT07627711

Recruiting

Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma (DUAL-NK-PDAC)

Metastatic Disease | Pancreatic Ductal Adenocarcinoma (PDAC) | Unresectable Locally Advanced
NCT06326983

Completed

Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery

Pain | Emergence Delirium | Anesthesia | Tonsillitis | Opioid Analgesic Adverse Reaction | Post-operative Nausea and Vomiting (PONV)
NCT04678063

Completed

Validation of Strasbourg Environmental Exposure Chamber ALYATEC in Cat Allergic Subjects With Asthma

Allergy | Allergic Asthma | Allergy to Cats
NCT03290313

Unknown

Clinical Trial Scheme of Shu Gan yi Yang Capsule

Depression With Erectile Dysfunction
NCT07589517

Recruiting

Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer (DUO-CRC-NK-111)

Colorectal Cancer | Metastatic Colorectal Adenocarcinoma | Unresectable Colorectal Cancer
NCT07575919

Recruiting

Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALL

B-cell Acute Lymphoblastic Leukemia
NCT07505199

Not yet recruiting

Safety and Efficacy of FAP iCDC in Ischemia Cardiomyopathy

Cell Therapy | Ischemic Cardiomyopathy
NCT07487597

Recruiting

Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors

Solid Tumor
NCT07462650

Recruiting

Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer

Colorectal Cancer Metastatic | Adenocarcinoma of Colon
NCT07129642

Recruiting

Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease

Graves Disease
NCT06960902

Recruiting

Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study) (ATHERO-FH)

Familial Hypercholesterolemias | Atherosclerotic Cardiovascular Disease (ASCVD)
NCT06665295

Recruiting

THRIVE-CAR-T Digital App (THRIVE-CAR-T)

CAR T-Cell Therapy
NCT06574360

Recruiting

Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia

Schizophrenia
NCT06078800

Recruiting

A Study of YL-17231 in Patients With Advanced Solid Tumors

Advanced Solid Tumor
NCT06018363

Recruiting

Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection

GBM | High-Grade Gliomas | Brain Gliomas
NCT05858684

Recruiting

Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients

CAR-T Cell Therapy
NCT05846347

Recruiting

Phase I Clinical Study of GC012F Injection in Treatment of Refractory Systemic Lupus Erythematosus

CAR-T
NCT05842707

Recruiting

Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

Refractory or Relapsed B-cell Non-Hodgkin Lymphoma
NCT05488132

Recruiting

Administration of Anti-siglec-6 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)

Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia Refractory
NCT05129553

Not yet recruiting

Béa Applicator and Béa Cervical Cap Safety and Usability Study

Safety and Usability
NCT05085418

Recruiting

A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis

Autoimmune Diseases | Lupus Nephritis | Immune Nephritis
NCT04764331

Recruiting

A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

Central Centrifugal Cicatricial Alopecia
NCT04327960

Not yet recruiting

Risk Assessment Strategies in Pulmonary Embolism

Pulmonary Embolism
NCT04204642

Recruiting

SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA) (SENECA)

Cerebral Amyloid Angiopathy
NCT04033302

Recruiting

Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies

Acute Myeloid Leukemia | T-cell Acute Lymphoblastic Leukemia | T-cell Acute Lymphoblastic Lymphoma | NK Cell Lymphoma
NCT07644403

Enrolling by invitation

Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors. (IMC001 EpCAM)

Epithelial Cancer Patients
NCT07384312

Completed

Study on the Antidepressant Effects and Mechanism of Action of Cang-ai Volatile Oil Based on Near-Infrared Functional Brain Imaging and the NT-Trk Signalling Pathway

Depression Disorder
NCT06355908

Suspended

IL13Rα2 CAR-T for Patients With r/r Glioma (ENHANCING)

Glioma
NCT04428476

Active, not recruiting

Open-label Extension of the HOPE-2 Trial (HOPE-2-OLE)

Duchenne Muscular Dystrophy
NCT06052319

Completed

A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population (IPACE-CVD)

Coronary Artery Disease (CAD) | Peripheral Artery Disease (PAD)
NCT03829280

Completed

Cognitive Adaption Training-Effectiveness in Real-world Settings and Mechanism of Action (CAT-EM) (CAT-EM)

Schizophrenia | Schizoaffective Disorder
NCT04649112

Completed

Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies

Hematologic Malignancy | CD19 Expressing Malignancies
NCT02920866

Completed

Improving Rehabilitation Outcomes After Total Hip Arthroplasty

Osteoarthritis | Total Hip Arthroplasty
NCT04499339

Active, not recruiting

A Phase I/IIa Clinical Trial to Assess Feasibility, Safety and Antitumor Activity of Autologous SLAMF7 CAR-T Cells in Multiple Myeloma

Multiple Myeloma
NCT04691401

Completed

Impact of Artificial Intelligence (AI) on Adenoma Detection During Colonoscopy in FIT+ Patients. (AIFIT)

Polyp of Colon

Search clinical trials for: Girls Can...Move!

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations